Hematology/Oncology

Top Story

FDA approves Keytruda for adjuvant treatment of melanoma

February 19, 2019
Guidelines

Updated Beers Criteria intended to reduce inappropriate medication use

February 19, 2019
The latest version of the American Geriatrics Society’s Beers Criteria provides guidance for clinicians on which medications most of their patients aged 65 years…
Feature

Breath test has 'potential to revolutionize' cancer detection, diagnosis

February 19, 2019
Researchers in the United Kingdom have launched a 2-year trial to evaluate whether a breath test can be used for early detection of multiple cancer types. The PAN trial…
In the Journals Plus

E-cigarette use rises among patients with cancer

February 18, 2019
Rates of electronic cigarette use among patients with cancer have risen over the past several years as rates of conventional smoking have remained steady, according to…
Meeting News

Early tumor shrinkage associated with OS benefit from cabozantinib in advanced kidney cancer

February 18, 2019
SAN FRANCISCO — Cabozantinib induced early tumor shrinkage — associated with prolonged OS — at a higher rate and to a greater degree than everolimus…
More Headlines »
CME ABIM MOC

Ace the Case: A 72-Year-Old, Healthy, and Asymptomatic Woman With Incidentally Diagnosed Leukemia

There is no commercial support for this activity.

This educational activity will discuss the management of a 72-year old, asymptomatic female with severe leukopenia…
More »
Video
Meeting News

VIDEO: Researchers link mutation to venetoclax resistance in chronic lymphocytic leukemia

December 17, 2018
More »
Resource Centers
ASH Annual Meeting and Exposition

ASH Annual Meeting and Exposition

CME CNE CPE

Advances in the Management of Toxicities Associated with Stem Cell Transplant

This activity is supported by an educational grant from Cumberland Pharmaceuticals.

Therapeutic options for the treatment of multiple myeloma continue to evolve. Currently, high-dose melphalan followed…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next